Real-world safety of Lacosamide: A pharmacovigilance study based on spontaneous reports in the FDA adverse event reporting system

Liu, PC; He, MJ; Xu, XL; He, Y; Yao, WB; Liu, B

Liu, B (通讯作者),Harbin Med Univ, Affiliated Hosp 4, Dept Neurol, Harbin 150001, Heilongjiang, Peoples R China.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2023; 110 (): 203

Abstract

Introduction: Lacosamide is licensed for the treatment of focal seizures in both adults and children, however there is little information available on......

Full Text Link